A review of cardiovascular complications accompanying AIDS

Cell Biochemistry and Function

Volumn 22, Issue 3, 2004, Pages 137-141

  Pugliese, A ^a   Gennero, L ^a   Vidotto, V ^a   Beltramo, T ^a   Petrini, S ^a   Torre, D ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Cardiovascular system involvement; HAART (Highly Active Antiretroviral Therapy); HIV 1 infection; Lipometabolism

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL ENDOCARDITIS; BRADYCARDIA; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; HEART ARRHYTHMIA; HEART INFARCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; ITALY; MACROPHAGE; MYOCARDITIS; NONHUMAN; PATHOPHYSIOLOGY; PERICARDITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME; SYSTEMIC VASCULITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOVASCULAR DISEASES; HUMANS; LIPID METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 2442578772     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1095     Document Type: Review

References (45)

1. Arshad A, Bansal A, Patel RC. Cardiac complications of human immunodeficiency virus infection: diagnostic and therapeutic considerations. Heart Dis 2000; 2: 133-145.
2. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000; 40: 282-284.
3. Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med 2001; 94: 384-390.
4. Dong KL, Bausserman LL, Flynn MM, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive patients on higly active antiretroviral therapy. J Acquir Immune Defic Syndr 1999; 21: 107-113.
5. Saint Marc T, Partisani M, Poizot Martin I, et al. Fat distribution evaluated by computed thomography and metabolic abnormalities in patients undergoing antiretroviral therapy. AIDS 2000; 14: 37-49.
6. Lewis W, Haase CP, Raidel SM, et al. Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice. Lab Invest 2001; 81: 1527-1536.
7. Cossarizza A, Troiano L, Mussini C. Mitochondria and HIV infection: the first decade. J Biol Regul Agents 2002; 16: 18-24.
8. Stenzel MS, Carpenter CC. The management of the clinical complications of antiretroviral therapy. Infect Dis Clin North Am 2000; 14: 851-878.
9. Harmon WG, Dadlani GH, Fisher SD, Lipshultz SE. Myocardial and pericardial disease in HIV. Curr Treat Options Cardiovasc Med 2002; 4: 497-509.
10. Kostka T, Lacour JR, Bonnefoy M. Response of blood lipids to physical exercise in elderly subjects. Prev Cardiol 2001; 4: 122-125.
11. Guillamon Toran L, Romeu Fontanillas J, Forcada Sainz JM, Curos Abadal A, Larousse Perez E, Valle Tudela V. Heart pathology of extracardiac origin (I). Cardiac involvement in AIDS. Rev Esp Cardiol 1997; 50: 721-728.
12. Rerkpattanapipat P, Wongraparut N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 2000; 160: 602-608.
13. Barbaro G, Lipshultz SE. Pathogenesis of HIV-associated cardiomyopathy. Ann NY Acad Sci 2001; 946: 57-81.
14. Lewis W. AIDS cardiomyopathy: physiological, molecular, and biochemical studies in the transgenic mouse. Ann NY Acad Sci 2001; 946: 46-56.
15. Gisselbrecht M. Vasculitis during human acquired immunodeficiency virus infection. Pathol Biol (Paris) 1999; 47: 245-247.
16. Niakara A, Drabo YJ, Kambire Y, Nebie LV, Kabore NJ, Simon F. Cardiovascular diseases and HIV infection: study at the National Hospital of Ougadougou (Burkina Faso). Bull Soc Pathol Exot 2002; 95: 23-26.
17. Niakara A, Kambire Y, Drabo YJ. Pericarditis in HIV infected patients: retrospective sudy of 40 cases in Ouagadougou, Burkina Faso. Sante 2001; 11: 167-172.
18. Longo-Mbenza B, Seghers KV, Phuati M, Bikangi FN, Mubagwa K. Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol 1998; 64: 63-73.
19. Nzuobontane D, Ngu BK, Christopher K. Cardiovascular autonomic dysfunction in Africans infected with human immunodeficiency virus. J R Soc Med 2002; 95: 445-447.
20. Nzuobontane D, Blackett KN, Kuaban C. Cardiac involvement in HIV infected people in Yaounde, Cameroon. Postgrad Med J 2002; 78: 678-681.
21. Langston C, Cooper ER, Goldfarb J, et al. and the P2C2 HIV Study Group. Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) study. Pediatrics 2001; 107: 328-338.
22. Cecchi E, Parrini I, Chinaglia A, et al. Cardiac complications in HIV infections. Ital Cardiol 1997; 27: 917-924.
23. Hakim JG, Temouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Hearth 2000; 84: 183-188.
24. Lanjewar DN, Katdare GA, Jain PP, Hira SK. Pathology of the heart in acquired immunodeficiency syndrome. Indian Heart J 1998; 50: 321-325.
25. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicentre clinical-pathological study. (Gruppo Italiano per lo studio cadiologico dei pazienti affetti da AIDS Investigators). AIDS Res Hum Retroviruses 1998; 14: 1071-1077.
26. Plein D, Van Camp G, Cosyns B, Alimenti A, Levy J, Vandenbossche JL. Cardiac and autonomic evaluation in a pediatric population with human immunodeficiency virus. Clin Cardiol 1999; 22: 33-36.
27. Miro JM, del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-infected patients. Infect Dis Clin North Am 2002; 16: 273-295.
28. Cicalini S, Forcina G, De Rosa FG. Infective endocarditis in patients with human immunodeficiency virus infection. J Infect 2001; 42: 267-271.
29. Liu QN, Reddy S, Sayre JW, Pop V, Graves MC, Fiala M. Essential role of HIV type 1-infected and cyclooxygenase 2-activated macrophages and T cells in HIV type 1 myocarditis. AIDS Res Hum Retroviruses 2001; 17: 1423-1433.
30. Tomei LD, Umansky SR. Apoptosis and the heart: a brief review. Ann NY Acad Sci 2001; 946: 160-168.
31. Twu C, Liu NQ, Popik W, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci USA 2002; 99: 14386-14391.
32. Fantoni M, Autore C, Del Borgo C. Drugs and cardiotoxicity in HIV and AIDS. Ann NY Acad Sci 2001; 946: 179-199.
33. Yunis NA, Stone VE. Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 145-154.
34. Milei J, Grana D, Fernandez Alonso G, Matturri L. Cardiac involvement in acquired immunodeficiency syndrome: a review to push action. The Committee for the study of cardiac involvement in AIDS. Clin Cardiol 1998; 21: 465-472.
35. Aim JL, Orlando B, Cantin-Betraux D, Pourriat JL. Myocardial infarction in AIDS. Ann Fr Anesth Reanim 2002; 21: 741-743.
36. Law M, Friis-Moller N, Weber R, et al. and the DAD Study Group. Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study. HIV Med 2003; 4: 1-10.
37. Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res 2000; 18: 329-333.
38. Gurgo AM, Massino Ferri F, Iulianella R, et al. Acute myocardial infarct in HIV-positive patients in treatment with protease inhibitors. Ital Heart J 2001; 2: 1236-1239.
39. Sposito AC, Caramelli B, Sartori AM, Ramires JA. The lipoprotein profile in HIV infected patients. Braz J Infect Dis 1997; 1: 275-283.
40. Kikuchi Y, Genka I, Ishizaki A, Sunagawa K, Yasuoka A, Oka S. Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome. Clin Infect Dis 35: 488-490.
41. Guillevin L, Cohen P. Management of virus-induced systemic vasculitides. Curr Rheumatol Rep 2002; 4: 60-66.
42. Fabris P, Tositti G, Giordani MT, et al. Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus. J Med Virol 2003; 69: 339-343.
43. Izycka-Swieszewska E, Zoltowska A, Rzepko R, Gross M, Borowska-Lehman J. Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS). Folia Neuropathol 2000; 38: 175-182.
44. Aoun S, Ramos E. Hypertension in the HIV-infected patient. Curr Hypertens Rep 2000; 2: 478-481.
45. Torre D, Pugliese A, Orofino G. Effect of highly active antiretroviral therapy on ischemic cardiovascular disease in patients with HIV-1 infection. Clin Infect Dis 2002; 35: 631-632 (Letter).